Sunrise, a company operating in the field of sleep health, attracted an investment of 29 million US dollars in its latest funding round. This demonstrates the company's future plans and its focus on sleep health technologies. This investment is an important step for the company's development and expansion.
Redaksiya reports that this funding round was led by Eurazeo. Other investors participating in the investment round for Belgium-based Sunrise included Amazon's Alexa Fund, WE International, Kurma Partners, Vives Fund, Majycc, Namur Invest, Seventure Partners, Investsud, Sambrinvest, Noshaq, IMBC, and Invest.BW. The company announced that it would use the new investment to accelerate Dreem Health's domestic growth, expand its clinical services, and invest in next-generation sleep technologies.
Sunrise was founded in 2015 by Laurent Martinot. As a pioneering organization in sleep health technologies, the company has developed a lightweight and portable device aimed at diagnosing sleep apnea at home. This device has been approved by the FDA and validated in studies conducted with the participation of experts. Thanks to this device, it is possible to reliably detect sleep apnea by monitoring jaw movements during sleep. Its lightweight and portable nature ensures that patients can obtain accurate results at home without having to visit sleep laboratories. Sunrise does not limit itself to device development. At the same time, it offers online consultation and personalized services through Dreem Health, a digital sleep clinic in the USA. Sunrise focuses on creating a new standard in sleep health with its home-applicable technologies and digital clinical services, offering an alternative to classic sleep laboratory methods.